| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Agricultural Economics, Cornell University, Ithaca, NY 14853
This paper estimates the cost of mastitis for the New York dairy sector. The average cost is found to be $125 per cow from reduced milk production, treatment, and increased culling. At the 1988 cow inventory, this translates to approximately $100 million annually for the entire dairy farm sector. When quality and production losses for the processing sector are added, the cost to the New York industry alone is nearly $150 million annually. Two promising new treatments, a bacteriocin and a vaccine, are evaluated. Both have shown effectiveness in preliminary trials against Staphylococcus aureus. Assuming that further development will allow the treatments to be effective against the major bacterial sources of mastitis infections, the treatments are projected to increase the annual income of the New York dairy industry by $18.8 to $39.7 million. The bacteriocin could replace antibiotic usage, a desirable goal in the opinion of many, and the vaccine promises to immunize cows against mastitis very effectively.
Key Words: mastitis • economics • biotechnology
Submitted on April 29, 1991
Accepted on September 30, 1991
This article has been cited by other articles:
|
|
 |
|
  J. Chen and R. P. Novick Phage-Mediated Intergeneric Transfer of Toxin Genes Science, January 2, 2009; 323(5910): 139 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aires-de-Sousa, C. E. S. R. Parente, O. Vieira-da-Motta, I. C. F. Bonna, D. A. Silva, and H. de Lencastre Characterization of Staphylococcus aureus Isolates from Buffalo, Bovine, Ovine, and Caprine Milk Samples Collected in Rio de Janeiro State, Brazil Appl. Envir. Microbiol., June 15, 2007; 73(12): 3845 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S Smyth, P. J Hartigan, W. J Meaney, J R. Fitzgerald, C. F Deobald, G. A Bohach, and C. J Smyth Superantigen genes encoded by the egc cluster and SaPIbov are predominant among Staphylococcus aureus isolates from cows, goats, sheep, rabbits and poultry J. Med. Microbiol., April 1, 2005; 54(4): 401 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gilot and W. van Leeuwen Comparative Analysis of agr Locus Diversification and Overall Genetic Variability among Bovine and Human Staphylococcus aureus Isolates J. Clin. Microbiol., March 1, 2004; 42(3): 1265 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bower, S. P. Djordjevic, N. M. Andronicos, and M. Ranson Cell Surface Antigens of Mycoplasma Species Bovine Group 7 Bind to and Activate Plasminogen. Infect. Immun., August 1, 2003; 71(8): 4823 - 4827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Fitzgerald, S. R. Monday, T. J. Foster, G. A. Bohach, P. J. Hartigan, W. J. Meaney, and C. J. Smyth Characterization of a Putative Pathogenicity Island from Bovine Staphylococcus aureus Encoding Multiple Superantigens J. Bacteriol., January 1, 2001; 183(1): 63 - 70. [Abstract] [Full Text]
|
|
|
|
|
|
D. McKenney, K. L. Pouliot, Y. Wang, V. Murthy, M. Ulrich, G. Döring, J. C. Lee, D. A. Goldmann, and G. B. Pier Broadly Protective Vaccine for Staphylococcus aureus Based on an in Vivo-Expressed Antigen Science, May 28, 1999; 284(5419): 1523 - 1527. [Abstract] [Full Text]
|
|
|
|
|
|
D. Iannelli, L. D'Apice, D. Fenizia, L. Serpe, C. Cottone, M. Viscardi, and R. Capparelli Simultaneous Identification of Antibodies to Brucella abortus and Staphylococcus aureus in Milk Samples by Flow Cytometry J. Clin. Microbiol., March 1, 1998; 36(3): 802 - 806. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
